How often should TCT and HPV tests be performed?

TCT refers to liquid-based thin-layer cytology testing, and HPV refers to human papillomavirus testing. Generally, for healthy women, it is recommended to undergo either TCT or HPV testing every three years. Detailed analysis is as follows:

For healthy women aged 21-29 years, the HPV infection rate is relatively high, but most infections are transient and can be cleared by the body's immune system. The probability of developing cervical precancerous lesions or cervical cancer is relatively low. Performing TCT testing alone can effectively detect cellular abnormalities. Therefore, annual testing is unnecessary. A screening interval of every three years ensures effective screening while reducing unnecessary testing burdens and costs.

As age increases, so does the risk of developing cervical cancer. For women aged 30-65 years, combined screening with TCT and HPV is recommended to improve screening accuracy and enable more precise detection of potential lesions. This approach allows for both the identification of abnormal cervical cell changes and the assessment of high-risk HPV infection. Such combined screening facilitates early detection and timely intervention.

In summary, the screening intervals for TCT and HPV testing may vary individually. Based on personal circumstances and under professional medical guidance, individuals can choose an appropriate screening frequency. This ensures effective early screening and prevention of cervical cancer, thus maintaining personal health.